ArticleThe Lancet. Rheumatology2022

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period.

Laura Boekel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.